FDA
-
-
-
-
-
-
-
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
-
-
-
-
-
-
-
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
-
-
-
-
-
-
-
Orchard Therapeutics Announces Presentation of Data Comprising the Clinical Package for the OTL-200 BLA in MLD at the SSIEM Annual Symposium 2023
-
-
-
-
-
-
-
Key Biotech Events to Watch, Week of 5/15/2023
-
-
-
-
-
-
-
Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million
-
-
-
-
-
-
-
Orchard Therapeutics (ORTX) Granted FDA Clearance of IND Application for OTL-203 in MPS-IH
-
-
-
-
-
-
-
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

